SCN9A and paroxysmal extreme pain disorder: Point mutations of SCN9A that confer gain-of-function changes at the channel level have been linked to several pain disorders including inherited erythromelalgia (IEM)3–6 and paroxysmal extreme pain disorder (PEPD)7–9.